Organigram Holdings Archives

StaffDecember 19, 2023

The Daily Hit is a recap of the top financial news stories for Dec. 19, 2023. On the Site Missouri Regulators Find 11 Social Equity License Recipients Ineligible Nearly one-quarter of the 48 social equity marijuana microbusiness permits awarded in October have been deemed ineligible for various reasons, and the 11 applicants – which include […]

John SchroyerDecember 19, 2023

The company also announced its next CFO.

Debra BorchardtNovember 28, 2023

Canadian companies stand to gain the most from Germany's easing of restrictions.

StaffNovember 6, 2023

The Daily Hit is a recap of the top financial news stories for Nov. 6, 2023. On the Site Florida Medical Cannabis Company Suing State Over $1.3M License Fee One of Florida’s 24 medical marijuana businesses has filed suit against the state over its whopping $1.33 million biennial licensing fee, which was raised in December […]

Debra BorchardtOctober 18, 2023

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) gave investors a corporate update mostly centered on the company’s products. Organigram didn’t provide any financial numbers but did remind investors that its new fiscal year began on October 1, 2023, and will end on Sept. 30, 2024. The company said it would announce its full-year fiscal 2023 […]

StaffSeptember 26, 2023

The Daily Hit is a recap of the top financial news stories for Sept. 26, 2023. On the Site Lucy Scientific Mum on High Times Deal The recent acquisition of High Times Holding Corp. by Lucy Scientific Discovery Inc. (NASDAQ: LSDI) raised many questions – but the company doesn’t appear to want to answer them. […]

Adam JacksonSeptember 26, 2023

A potential M&A spree is brewing, though investors could see their shares diluted.

Adam JacksonAugust 1, 2023

Zuanic predicted continued growth in Canadian market despite seasonal variances.

Adam JacksonJuly 14, 2023

Management says it is focused on sustainable long-term growth.

StaffApril 12, 2023

The Daily Hit is a recap of the top financial news stories for April 12, 2023. On the Site Organigram Delivers Solid Quarter, Forecasts Rising Revenue Organigram reported that its net revenue increased 24% to $39.5 million, from $31.8 million in the same time period in 2022. The company attributed the increase to an increase […]

Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC

Functional Mushrooms Move Into Mainstream as Wellness Trend Grows

In other news

The Daily Hit: January 4, 2024

Connecticut Attorney General Tells Unlicensed Cannabis Events Company to Stop

Testing Concerns Lead to Quarantine for 70% of Mississippi MMJ Goods

Tag: Organigram Holdings

The Daily Hit: December 19, 2023

Organigram Loses Nearly a Quarter Billion in 2023

Germany Lurches Forward on Cannabis Program Expansion

The Daily Hit: November 6, 2023

Organigram Grows Market Share in Pre-Rolls

The Daily Hit: September 26, 2023

Organigram Holdings Seeks C$500 Million Financing Approval

Canadian Adult-Use Cannabis Sales Reveal Robust Growth, Outpace US Market

Organigram Reports Q3 Revenue Drop and Rising Costs

Daily Hit: April 12, 2023

The Daily Hit - TEST TEST TEST

Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC

Functional Mushrooms Move Into Mainstream as Wellness Trend Grows

Get the latest cannabis news delivered right to your inbox